23 employees
KAEX is a patent pending nutraceutical / otc pharmaceutical
2016
$1.2M
from 2 investors over 2 rounds
ph. International raised $1.2M on March 2, 2023
Investors: Artemon Capital Partners
ph. International raised undisclosed on April 3, 2019
Investors: ProSiebenSat.1 Accelerator